{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:01:14Z","timestamp":1792512074722,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"am","delay-in-days":276,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL155265-01"],"award-info":[{"award-number":["1R01HL155265-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1R01-HL-13 0301-01"],"award-info":[{"award-number":["1R01-HL-13 0301-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1R01-HL-147639-01A1"],"award-info":[{"award-number":["1R01-HL-147639-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["21PRE830396"],"award-info":[{"award-number":["21PRE830396"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vph.2024.107288","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T12:26:37Z","timestamp":1709123197000},"page":"107288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["12-week Dolutegravir treatment marginally reduces energy expenditure but does not increase body weight or alter vascular function in a murine model of Human Immunodeficiency Virus infection"],"prefix":"10.1016","volume":"155","author":[{"given":"Taylor C.","family":"Kress","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Ajala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleton R.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodger","family":"MacArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kennard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Antonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Belin de Chantem\u00e8le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vph.2024.107288_bb0005","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","article-title":"Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care","volume":"73","author":"Marcus","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.vph.2024.107288_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11904-014-0219-7","article-title":"Metabolic syndrome, diabetes, and cardiovascular risk in HIV","volume":"11","author":"Nix","year":"2014","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-6405-10-32","article-title":"Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects","volume":"10","author":"Paula","year":"2013","journal-title":"AIDS Res. Ther."},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2016.09.979","article-title":"HIV and ischemic heart disease","volume":"69","author":"Vachiat","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2024.107288_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","article-title":"HIV and coronary heart disease: time for a better understanding","volume":"61","author":"Boccara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.vph.2024.107288_bb0035","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","volume":"170","author":"Lang","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.vph.2024.107288_bb0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:a:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"17","key":"10.1016\/j.vph.2024.107288_bb0045","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"D.A.D.S. Group","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.vph.2024.107288_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010956","article-title":"Risk factors associated with overweight and obesity in HIV-infected people: aging, behavioral factors but not cART in a cross-sectional study","volume":"97","author":"Obry-Roguet","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"A.C.C.o.R. North American, Design, Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada","volume":"32","author":"Koethe","year":"2016","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"17","key":"10.1016\/j.vph.2024.107288_bb0060","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2022.08.756","article-title":"Veterans aging cohort, circulating T cells and cardiovascular risk in people with and without HIV infection","volume":"80","author":"Kundu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2024.107288_bb0065","series-title":"Pre-Exposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review for the U.S. Preventive Services Task Force, Rockville (MD)","author":"Chou","year":"2023"},{"issue":"9","key":"10.1016\/j.vph.2024.107288_bb0070","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1016\/S2352-3018(23)00141-8","article-title":"Metabolic implications and safety of dolutegravir use in pregnancy","volume":"10","author":"Dontsova","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.vph.2024.107288_bb0075","first-page":"503","article-title":"Hyperglycemia after Dolutegravir-based antiretroviral therapy","volume":"14","author":"Hailu","year":"2021","journal-title":"Int Med Case Rep J"},{"issue":"10","key":"10.1016\/j.vph.2024.107288_bb0080","article-title":"Effect of Dolutegravir on plasma glucose among human immunodeficiency virus patients in a community health center setting","volume":"14","author":"Bahamdain","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.vph.2024.107288_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101836","article-title":"Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa","volume":"57","author":"Brennan","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0090","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4102\/sajhivmed.v23i1.1452","article-title":"Effect of obesity on dolutegravir exposure in black southern African adults living with HIV","volume":"23","author":"Mondleki","year":"2022","journal-title":"South Afr J HIV Med"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","article-title":"HIV and antiretroviral therapy-related fat alterations","volume":"6","author":"Koethe","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"7","key":"10.1016\/j.vph.2024.107288_bb0100","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(22)00094-7","article-title":"Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium","volume":"9","author":"Neesgaard","year":"2022","journal-title":"Lancet HIV"},{"issue":"47","key":"10.1016\/j.vph.2024.107288_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005465","article-title":"Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patients","volume":"95","author":"Mahlab-Guri","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0042-6822(91)90759-5","article-title":"HIV-associated nephropathy in transgenic mice expressing HIV-1 genes","volume":"185","author":"Dickie","year":"1991","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vph.2024.107288_bb0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1073\/pnas.89.5.1577","article-title":"Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes","volume":"89","author":"Kopp","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"46","key":"10.1016\/j.vph.2024.107288_bb0120","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1073\/pnas.1615258113","article-title":"Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice","volume":"113","author":"Carroll","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.vph.2024.107288_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.mnh.0000222688.69217.8e","article-title":"Animal models of HIV-associated nephropathy","volume":"15","author":"Lu","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4","key":"10.1016\/j.vph.2024.107288_bb0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cts.12331","article-title":"Cardiac dysfunction in HIV-1 transgenic mouse: role of stress and BAG3","volume":"8","author":"Cheung","year":"2015","journal-title":"Clin. Transl. Sci."},{"issue":"21","key":"10.1016\/j.vph.2024.107288_bb0135","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by tat: implications for in vivo expansion of coreceptor use by HIV-1","volume":"97","author":"Xiao","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.vph.2024.107288_bb0140","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","article-title":"Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 tat","volume":"103","author":"Poggi","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187152612798994939","article-title":"Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein","volume":"12","author":"Mediouni","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12974-018-1322-2","article-title":"Adult neurogenic deficits in HIV-1 Tg26 transgenic mice","volume":"15","author":"Putatunda","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.vph.2024.107288_bb0155","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1042\/CS20160073","article-title":"Ptp1b deletion in pro-opiomelanocortin neurons increases energy expenditure and impairs endothelial function via TNF-alpha dependent mechanisms","volume":"130","author":"Bruder-Nascimento","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.vph.2024.107288_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107093","article-title":"Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice","volume":"146","author":"Atawia","year":"2022","journal-title":"Vasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.vph.2024.107288_bb0165","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/HYPERTENSIONAHA.121.18832","article-title":"Midgestation leptin infusion induces characteristics of clinical preeclampsia in mice, Which Is Ablated by Endothelial Mineralocorticoid Receptor Deletion","volume":"79","author":"Faulkner","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2024.107288_bb0170","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1093\/cid\/ciaa1652","article-title":"Transition to Dolutegravir is associated with an increase in the rate of body mass index change in a cohort of virally suppressed adolescents","volume":"73","author":"Thivalapill","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vph.2024.107288_bb0175","article-title":"The uncoupling proteins: a systematic review on the mechanism used in the prevention of oxidative stress","volume":"11","author":"Hirschenson","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0180","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12879-023-08174-3","article-title":"Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda","volume":"23","author":"Guaraldi","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.vph.2024.107288_bb0185","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1093\/cid\/ciaa259","article-title":"The integrase inhibitors Dolutegravir and Raltegravir exert Proadipogenic and Profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes","volume":"71","author":"Gorwood","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.vph.2024.107288_bb0190","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment-naive persons starting Dolutegravir-based antiretroviral therapy","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"13","key":"10.1016\/j.vph.2024.107288_bb0195","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.18632\/aging.204166","article-title":"Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 tat expression in male mice","volume":"14","author":"Qrareya","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"20","key":"10.1016\/j.vph.2024.107288_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010977","article-title":"Chronic exposure to HIV-derived protein tat impairs endothelial function via indirect alteration in fat mass and Nox1-mediated mechanisms in mice","volume":"22","author":"Kovacs","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.vph.2024.107288_bb0205","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacbts.2021.10.017","article-title":"HIV, Combination antiretroviral therapy, and vascular diseases in men and women","volume":"7","author":"Kovacs","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.vph.2024.107288_bb0210","first-page":"76","article-title":"Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches","volume":"4","author":"Weinroth","year":"1995","journal-title":"Infect. Agents Dis."},{"issue":"8","key":"10.1016\/j.vph.2024.107288_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3512","article-title":"Impact of inflammatory cytokine and adipokine gene variations in the development of HIV-associated lipodystrophy","volume":"25","author":"Namdev","year":"2023","journal-title":"J. Gene Med."},{"issue":"7","key":"10.1016\/j.vph.2024.107288_bb0220","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/cid\/ciad321","article-title":"Australian, H.I.V.i. New Zealand study group for cryptococcosis in patients without, Current epidemiology and clinical features of Cryptococcus infection in patients without HIV infection: a multicentre study in 46 hospitals from Australia and New Zealand","volume":"77","author":"Coussement","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.vph.2024.107288_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25899","article-title":"Weight gain during the dolutegravir transition in the African cohort study","volume":"25","author":"Esber","year":"2022","journal-title":"J. Int. AIDS Soc."},{"issue":"3","key":"10.1016\/j.vph.2024.107288_bb0230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3947\/ic.2022.0063","article-title":"Weight gain and lipid profile changes in Koreans with human immunodeficiency virus undergoing integrase Strand transfer inhibitor-based regimens","volume":"54","author":"Kim","year":"2022","journal-title":"Infect Chemother"},{"issue":"1","key":"10.1016\/j.vph.2024.107288_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society-USA panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vph.2024.107288_bb0240","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10439-012-0702-5","article-title":"Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice","volume":"41","author":"Hansen","year":"2013","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.vph.2024.107288_bb0245","series-title":"Global status report on noncommunicable disaeses 2010","year":"2011"},{"issue":"6","key":"10.1016\/j.vph.2024.107288_bb0250","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/HYPERTENSIONAHA.118.11303","article-title":"Lack of suppression of aldosterone production leads to salt-sensitive hypertension in female but not male Balb\/C mice","volume":"72","author":"Faulkner","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2024.107288_bb0255","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/HYPERTENSIONAHA.119.12802","article-title":"Progesterone predisposes females to obesity-associated leptin-mediated endothelial dysfunction via upregulating endothelial MR (mineralocorticoid receptor) expression","volume":"74","author":"Faulkner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2024.107288_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/MSMBR.900437","article-title":"Cardiac hypertrophy: an introduction to molecular and cellular basis","volume":"22","author":"Samak","year":"2016","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"11","key":"10.1016\/j.vph.2024.107288_bb0265","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1093\/jac\/dkaa292","article-title":"Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease","volume":"75","author":"Gonzalez-Cordon","year":"2020","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:11Z","timestamp":1778617571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"alternative-id":["S1537189124000132"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107288","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"12-week Dolutegravir treatment marginally reduces energy expenditure but does not increase body weight or alter vascular function in a murine model of Human Immunodeficiency Virus infection","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107288"}}